GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 207 filers reported holding GENMAB A/S in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,564,754 | +639.3% | 44,365 | +696.8% | 0.01% | +500.0% |
| Q2 2023 | $211,640 | -7.9% | 5,568 | -8.5% | 0.00% | 0.0% |
| Q1 2023 | $229,883 | -26.6% | 6,088 | -17.6% | 0.00% | -50.0% |
| Q4 2022 | $313,231 | +296.5% | 7,391 | +202.7% | 0.00% | +100.0% |
| Q2 2022 | $79,000 | -17.7% | 2,442 | -8.1% | 0.00% | 0.0% |
| Q1 2022 | $96,000 | +47.7% | 2,658 | +62.0% | 0.00% | – |
| Q4 2021 | $65,000 | +4.8% | 1,641 | +16.1% | 0.00% | -100.0% |
| Q3 2021 | $62,000 | +31.9% | 1,414 | +23.2% | 0.00% | – |
| Q2 2021 | $47,000 | +34.3% | 1,148 | +8.5% | 0.00% | – |
| Q1 2021 | $35,000 | +118.8% | 1,058 | +164.5% | 0.00% | – |
| Q4 2020 | $16,000 | +6.7% | 400 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |